Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 2.875% 2/1
-
Number of holders
-
16
-
Total 13F principal, excl. options
-
228,151,727
-
Principal change
-
-3,317,880
-
Total reported value, excl. options
-
$268,334,805
-
Value change
-
-$4,307,514
-
Number of buys
-
8
-
Number of sells
-
7
-
Price
-
$1.11
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 as of Q2 2024
As of 30 Jun 2024 COLLEGIUM PHARMACEUTICAL INC - NOTE 2.875% 2/1 had 19 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $228,151,727 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Linden Advisors LP, WHITEBOX ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, STEELHEAD PARTNERS LLC, LAZARD ASSET MANAGEMENT LLC, BNP PARIBAS FINANCIAL MARKETS, HIGHBRIDGE CAPITAL MANAGEMENT LLC, BlueCrest Capital Management Ltd, Jefferies Financial Group Inc., and SSI INVESTMENT MANAGEMENT LLC.
This table shows 19 bond principal holders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.